Quotes Synovics Pharmaceuticals, Inc.

Equities

SYVC

US87163M1018

Pharmaceuticals

Market Closed - OTC Markets 19:10:02 04/08/2023 BST 5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -.--%
10 years-97.78%

Performance

3 years-50.00%
10 years-97.78%

Volumes

markets
Daily volume
400
Estimated daily volume
400
Record volume 1
551 560
Record volume 2
485 140
Record volume 3
332 060
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (USD)
3 648
Net sales (USD)
25 959 579
Number of employees
155
Sales / Employee (USD)
167 481
Free-Float
95.75 %
Free-Float capitalization (USD)
2 982

Highs and lows

1 year
0.00
Extreme 0.0001
0.00
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.01

Indicators

RSI 9 days
45.38
RSI 14 days
47.14

Sector Comparison - Other Pharmaceuticals

Name Change 5d. change 1st Jan change 1-year change Capi.
-.--%-.--%-.--% - 3.65K
+0.05%+0.58%+38.59%+89.09% 727B
-1.76%-4.54%-7.89%-6.47% 354B
-2.63%-3.57%+15.66%+15.50% 328B
-1.10%-4.66%+0.24%+13.85% 277B
-2.18%-0.56%+13.47%+2.07% 243B
-1.00%-2.42%+7.35%+2.47% 205B
-0.48%-3.50%-6.42%-21.29% 203B
-1.85%-4.66%+4.23%+37.37% 164B
-2.01%-0.91%-1.70%-23.53% 164B
-1.42%-1.58%-1.31%-10.48% 122B
-1.94%-1.97%+19.98%+24.98% 92.44B
-1.82%-4.21%-21.09%-36.45% 83.6B
-2.65%-4.98%-21.07%-16.23% 81.83B
-2.35%-0.65%+41.92%+21.92% 68.79B
-.--%+1.73% - - 63.66B
Average-1.22%-1.02%+5.46%+6.63%
Weighted average by Cap.-1.04%-0.44%+11.38%+22.00%

Historical data

DateOpeningHighLowEnd-of-dayVolume
Chart Synovics Pharmaceuticals, Inc.
More charts

Monthly variations

Annual change

2023+9,900.00%
2022-98.73%
2021+7,800.00%
2020-99.00%
2019-.--%
2018+9,900.00%
2017-99.98%
2014+5.00%
2013+90.48%
2012-81.74%
2011+130.00%
2010-96.67%
2009-34.78%
2008-48.31%
2007-73.98%
2006-22.27%
2005+109.52%
2004+10,400.00%
2003-95.00%
2002-93.85%
2001+30.00%
2000-74.19%
1999+29.17%
1998-80.49%
1997-20.13%
1996+3,750.00%
1995-75.00%
  1. Stock Market
  2. Equities
  3. SYVC Stock
  4. Quotes Synovics Pharmaceuticals, Inc.